TY - JOUR
T1 - A refined long RT-PCR technique to amplify complete viral RNA genome sequences from clinical samples
T2 - Application to a novel hepatitis C virus variant of genotype 6
AU - Lu, Ling
AU - Nakano, Tatsunori
AU - Smallwood, Gregory A.
AU - Heffron, Thomas G.
AU - Robertson, Betty H.
AU - Hagedorn, Curt H.
N1 - Funding Information:
This work was supported in part by NIH grant 5 P20 RR016443-04 (CHH) and CA0630 64 (CHH).
PY - 2005/6
Y1 - 2005/6
N2 - The goal of this study was to adapt a long RT-PCR technique to amplify large PCR fragments from the genome of hepatitis C virus (HCV) isolates using clinical samples. This was done by using a reverse transcriptase devoid of RNase H activity and a mixture of two antibody-bound thermostable polymerases to combine the high processivity of Taq and the high fidelity of Pwo with its 3′ → 5′ exonuclease activity. Other modifications included gentle handling during RNA extraction, the absence of tRNA and random primers, a two-step reverse transcription procedure to optimize cDNA synthesis, and increasing the annealing temperature for primers. With this approach, the HCV-1 genome (nucleotides 35-9282) was amplified consistently as two overlapping fragments of 5344 and 4675 bp from a pooled chimpanzee plasma sample containing approximately 106 genome copies of HCV RNA/ml. Using the conditions that we identified, 96% of the complete genomic sequence of a distinct HCV genotype 6 variant (km45) was determined from less than 300 μl of serum. This method should prove useful for molecular, epidemiological and clinical studies of hepatitis C where samples are limited but complete virus sequence is required, for example, identifying mutational hot spots of HCV under specific clinical conditions.
AB - The goal of this study was to adapt a long RT-PCR technique to amplify large PCR fragments from the genome of hepatitis C virus (HCV) isolates using clinical samples. This was done by using a reverse transcriptase devoid of RNase H activity and a mixture of two antibody-bound thermostable polymerases to combine the high processivity of Taq and the high fidelity of Pwo with its 3′ → 5′ exonuclease activity. Other modifications included gentle handling during RNA extraction, the absence of tRNA and random primers, a two-step reverse transcription procedure to optimize cDNA synthesis, and increasing the annealing temperature for primers. With this approach, the HCV-1 genome (nucleotides 35-9282) was amplified consistently as two overlapping fragments of 5344 and 4675 bp from a pooled chimpanzee plasma sample containing approximately 106 genome copies of HCV RNA/ml. Using the conditions that we identified, 96% of the complete genomic sequence of a distinct HCV genotype 6 variant (km45) was determined from less than 300 μl of serum. This method should prove useful for molecular, epidemiological and clinical studies of hepatitis C where samples are limited but complete virus sequence is required, for example, identifying mutational hot spots of HCV under specific clinical conditions.
UR - http://www.scopus.com/inward/record.url?scp=17644421360&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=17644421360&partnerID=8YFLogxK
U2 - 10.1016/j.jviromet.2005.01.031
DO - 10.1016/j.jviromet.2005.01.031
M3 - Article
C2 - 15847930
AN - SCOPUS:17644421360
SN - 0166-0934
VL - 126
SP - 139
EP - 148
JO - Journal of Virological Methods
JF - Journal of Virological Methods
IS - 1-2
ER -